Jeffrey K. Lee, MD, MAS

People

Kaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

jeffrey.k.lee@kp.org

Jeffrey K. Lee, MD, MAS, is a Research Scientist I at the Kaiser Permanente Northern California Division of Research and an attending gastroenterologist at Kaiser Permanente San Francisco Medical Center. His clinical focus is in general gastroenterology, colorectal cancer prevention, and hereditary gastrointestinal cancer syndromes. His research interests include: colorectal cancer prevention, gastrointenstinal cancer prevention, pharmacoepidemiology, diagnostic testing for gastrointestinal cancers, and improving the quality and safety of endoscopy and colonoscopy. He holds a Bachelor of Arts from the University of California, Berkeley, a Masters in Clinical Research from the University of California, San Diego, and a Doctorate in Medicine, also from UCSD. After medical school, he completed an internal medicine residency at UCSD; and a gastroenterology fellowship at the University of California, San Francisco. Prior to joining Kaiser Permanente, he practiced gastroenterology at UCSF Medical Center for several years.

Current Position(s):

Research Scientist I, Division of Research, Kaiser Permanente Northern California
Attending Gastroenterologist, Kaiser Permanente, San Francisco Medical Center
Assistant Clinical Professor of Medicine, University of California, San Francisco

Section Affiliations:

Cancer

Studies

Optimizing Long-Term Post-Polypectomy Surveillance for Colorectal Cancer Prevention Using a Prediction Rule Developed from a Large, Community-Based Cohort

Screening has been shown to reduce colorectal cancer incidence and mortality. However, screening has resulted in a growing cohort of patients with adenomatous polyps (adenomas), and little is known about effectively managing their post-polypectomy surveillance. With limited data available in the literature to determine the appropriate timing and frequency of follow-up colonoscopy for patients after adenoma removal, recommendations for post-polypectomy surveillance from our national guidelines have been imprecise at best. To fill this knowledge gap, this project aims to: 1) determine the long- term colorectal cancer risk in patients after colonoscopic polypectomy in a very large “real world” community-based population; 2) identify patient-, polyp-, and exam-related risk factors associated with incident colorectal cancer in these patients; and 3) develop a risk prediction model that will identify post- polypectomy patients at high and low risk for developing subsequent colorectal cancer.

Investigator: Lee, Jeffrey
Funder: National Cancer Institute

Highlighted Publications

Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy.

Author(s): Kidambi, Trilokesh D TD; Terdiman, Jonathan P JP; El-Nachef, Najwa N; Singh, Aparajita A; Kattah, Michael G MG; Lee, Jeffrey K JK

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2018 Jun 20;():. Epub 2018-06-20.

Current Position(s):

Section Affiliations:

Studies

Optimizing Long-Term Post-Polypectomy Surveillance for Colorectal Cancer Prevention Using a Prediction Rule Developed from a Large, Community-Based Cohort

Highlighted Publications

Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy.

Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing

Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis

Publications

The Utility and Cross-Validation of a Composite Physical Activity Score in Relation to Cardiovascular Health Indicators: Coronary Artery Risk Development in Young Adults

Negative withdrawal time: simple and efficient

Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening

Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study

Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large, Community-based Population.

Effect of I-scan Electronic Chromoendoscopy on Detection of Adenomas During Colonoscopy.

Novel variant of unknown significance in MUTYH in a patient with MUTYH-associated polyposis: a case to reclassify.

Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.

Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polyps.

An Unexpected Finding During Colonoscopy: Pinworms.

Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review

Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing

Endoscopy is of low yield in the identification of gastrointestinal neoplasia in patients with dermatomyositis: A cross-sectional study.

Surveillance for One or Two Small Adenomas: Low Risk Is Really Low Risk.

Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis.

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.

Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study

What makes a "good" colonoscopy quality indicator?

Factors Influencing Variation in Physician Adenoma Detection Rates; a Theory-Based Approach for Performance Improvement

Development and validation of an algorithm for classifying colonoscopy indication

Importance of determining indication for colonoscopy: implications for practice and policy original

Adjusting for Patient Demographics Has Minimal Effects on Rates of Adenoma Detection in a Large, Community-based Setting

Multitarget stool DNA testing for colorectal-cancer screening.

Adenoma detection rate and risk of colorectal cancer and death

Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis

Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.

The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer?

Association between serum interleukin-6 concentrations and mortality in older adults: the Rancho Bernardo study.

Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening.

Molecular Prognostic and Predictive Markers in Colorectal Cancer: Current Status.

Evidence for an hMSH3 defect in familial hamartomatous polyps.

Achalasia, alcohol-stasis, and acute necrotizing esophagitis: connecting the dots.

Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms.

Improving fecal occult blood testing compliance using a mailed educational reminder.

ArterioVenous Malformation within Jejunal Diverticulum: an unusual cause of massive gastrointestinal bleeding.

The inflammatory response in transgastric surgery: gastric content leak leads to localized inflammatory response and higher adhesive disease.

Generalized megaviscera of lupus: refractory intestinal pseudo-obstruction, ureterohydronephrosis and megacholedochus.

The impact of proton-pump inhibitors on intraperitoneal sepsis: a word of caution for transgastric NOTES procedures.

Endoscopy is accurate, safe, and effective in the assessment and management of complications following gastric bypass surgery.

Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.

Evidence for colorectal sarcomatoid carcinoma arising from tubulovillous adenoma.

Nonmetastatic cancer of the colon associated with pyogenic liver abscess.

Education and imaging. Gastrointestinal: glycogenic acanthosis.

Incidental finding of metastatic papillary thyroid carcinoma in a patient with primary hyperparathyroidism.